Your browser doesn't support javascript.
loading
Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome.
Rosiek, Violetta; Bocian-Jastrzebska, Agnes; Kos-Kudla, Beata.
Affiliation
  • Rosiek V; Department of Endocrinology and Neuroendocrine Tumors, Department of Pathophysiology and Endocrinology, Medical University of Silesia, 40-514 Katowice, Poland.
  • Bocian-Jastrzebska A; Department of Endocrinology and Neuroendocrine Tumors, Department of Pathophysiology and Endocrinology, Medical University of Silesia, 40-514 Katowice, Poland.
  • Kos-Kudla B; Department of Endocrinology and Neuroendocrine Tumors, Department of Pathophysiology and Endocrinology, Medical University of Silesia, 40-514 Katowice, Poland.
Cancers (Basel) ; 15(8)2023 Apr 18.
Article in En | MEDLINE | ID: mdl-37190276
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2023 Document type: Article Affiliation country: Poland Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2023 Document type: Article Affiliation country: Poland Country of publication: Switzerland